Roberto Zoffoli
Bristol-Myers Squibb (Belgium)(BE)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Heavy Metal Exposure and Toxicity, CAR-T cell therapy research, Heavy metals in environment, Pancreatic and Hepatic Oncology Research
Most-Cited Works
- → Biomonitoring of several toxic metal(loid)s in different biological matrices from environmentally and occupationally exposed populations from Panasqueira mine area, Portugal(2013)60 cited
- → Genotoxic effect of exposure to metal(loid)s. A molecular epidemiology survey of populations living and working in Panasqueira mine area, Portugal(2013)28 cited
- → Indirect treatment comparison of nivolumab versus placebo as adjuvant treatment for resected melanoma(2021)20 cited
- → Immunological alterations in individuals exposed to metal(loid)s in the Panasqueira mining area, Central Portugal(2014)12 cited
- → Improved benefit of continuing luspatercept therapy: sub-analysis of patients with lower-risk MDS in the MEDALIST study(2023)4 cited
- → Treatment-Switching Adjustment of Overall Survival in CheckMate 227 Part 1 Evaluating First-Line Nivolumab Plus Ipilimumab Versus Chemotherapy for Metastatic Nonsmall Cell Lung Cancer(2024)3 cited
- → 308 Indirect treatment comparison of nivolumab versus placebo as adjuvant treatment for melanoma(2020)1 cited
- → Safety of weight-based dosing of nivolumab with or without ipilimumab by body mass index (BMI) stratified by sex across 14 CheckMate clinical trials.(2020)